Literature DB >> 17033315

Epidemiology of inflammatory bowel disease.

Scott M Montgomery1, Anders Ekbom.   

Abstract

Despite the apparent continuous increase of the incidence of inflammatory bowel disease (IBD) in some populations, or some sections of populations such as British children, the origin of these conditions remains obscure. Epidemiological studies of specific risk factors continue to yield contradictory and inconclusive results. However, studies of exposure and comorbidity, coupled with genetic and molecular studies, expand our knowledge and will facilitate more sophisticated research in the near future. Our understanding of the genetic basis of IBD is improving, but genetic anticipation as an explanation for increasing incidence rates appears less probable. The benefit of giving up smoking has been demonstrated in Crohn's disease patients, because smoking influences disease activity. The increased cancer risk in IBD is a concern, but despite this, the overall mortality in IBD is no higher than that of the general population.

Entities:  

Year:  2002        PMID: 17033315     DOI: 10.1097/00001574-200207000-00004

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  8 in total

Review 1.  Diet therapy for inflammatory bowel diseases: The established and the new.

Authors:  Franziska Durchschein; Wolfgang Petritsch; Heinz F Hammer
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 2.  Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?

Authors:  Roberto Bringiotti; Enzo Ierardi; Rosa Lovero; Giuseppe Losurdo; Alfredo Di Leo; Mariabeatrice Principi
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 3.  Inflammatory bowel disease in the elderly.

Authors:  Syed Wasif Hussain; Darrell S Pardi
Journal:  Drugs Aging       Date:  2010-08-01       Impact factor: 3.923

Review 4.  Diet, gut microbes, and genetics in immune function: can we leverage our current knowledge to achieve better outcomes in inflammatory bowel diseases?

Authors:  Vanessa A Leone; Candace M Cham; Eugene B Chang
Journal:  Curr Opin Immunol       Date:  2014-09-15       Impact factor: 7.486

5.  The role of N-acetyltransferase 2 polymorphism in the etiopathogenesis of inflammatory bowel disease.

Authors:  M Baranska; R Trzcinski; A Dziki; M Rychlik-Sych; M Dudarewicz; J Skretkowicz
Journal:  Dig Dis Sci       Date:  2011-02-15       Impact factor: 3.199

6.  A comprehensive review of inflammatory bowel disease focusing on surgical management.

Authors:  Seung Hyuk Baik; Won Ho Kim
Journal:  J Korean Soc Coloproctol       Date:  2012-06-30

7.  Heart Rate Recovery Is Impaired in Patients with Inflammatory Bowel Diseases.

Authors:  Bahadir Sarli; Yasemin Dogan; Orhan Poyrazoglu; Ahmet Oguz Baktir; Abdullah Eyvaz; Engin Altinkaya; Ahmet Tok; Engin Donudurmaci; Mehmet Ugurlu; Adile Ortakoyluoglu; Hayrettin Saglam; Huseyin Arinc
Journal:  Med Princ Pract       Date:  2016-05-10       Impact factor: 1.927

Review 8.  Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases.

Authors:  Vanessa Leone; Eugene B Chang; Suzanne Devkota
Journal:  J Gastroenterol       Date:  2013-03-12       Impact factor: 7.527

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.